164 related articles for article (PubMed ID: 20237507)
1. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
[No Abstract] [Full Text] [Related]
2. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.
Hockley SL; Giannouli S; Morilla A; Wotherspoon A; Morgan GJ; Matutes E; Gonzalez D
Br J Haematol; 2010 Feb; 148(4):666-9. PubMed ID: 19863540
[No Abstract] [Full Text] [Related]
3. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.
Behdad A; Bailey NG
Arch Pathol Lab Med; 2014 Oct; 138(10):1295-301. PubMed ID: 25268192
[TBL] [Abstract][Full Text] [Related]
4. V(H) gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin.
Vanhentenrijk V; Tierens A; Wlodarska I; Verhoef G; Wolf-Peeters CD
Leukemia; 2004 Oct; 18(10):1729-32. PubMed ID: 15356640
[No Abstract] [Full Text] [Related]
5. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment.
van Maldegem F; Wormhoudt TA; Mulder MM; Oud ME; Schilder-Tol E; Musler AR; Aten J; Saeed P; Kersten MJ; Pals ST; van Noesel CJ; Bende RJ
Leukemia; 2012 Jul; 26(7):1647-53. PubMed ID: 22382892
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profile in splenic marginal zone lymphoma.
Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A
Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
[No Abstract] [Full Text] [Related]
8. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.
Tierens A; Delabie J; Malecka A; Wang J; Gruszka-Westwood A; Catovsky D; Matutes E
Am J Pathol; 2003 Feb; 162(2):681-9. PubMed ID: 12547726
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?
Traverse-Glehen A; Baseggio L; Callet-Bauchu E; Ffrench M; Coiffier B; Salles G; Felman P; Berger F
Br J Haematol; 2010 Jul; 150(1):113-6. PubMed ID: 20230408
[No Abstract] [Full Text] [Related]
10. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
[TBL] [Abstract][Full Text] [Related]
11. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.
Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A
Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147
[No Abstract] [Full Text] [Related]
12. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
13. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes.
Miranda RN; Cousar JB; Hammer RD; Collins RD; Vnencak-Jones CL
Hum Pathol; 1999 Mar; 30(3):306-12. PubMed ID: 10088550
[TBL] [Abstract][Full Text] [Related]
15. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
16. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphomas appear to originate from different B cell types.
Bahler DW; Pindzola JA; Swerdlow SH
Am J Pathol; 2002 Jul; 161(1):81-8. PubMed ID: 12107092
[TBL] [Abstract][Full Text] [Related]
18. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
19. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
Hockley SL; Else M; Morilla A; Wotherspoon A; Dearden C; Catovsky D; Gonzalez D; Matutes E
Br J Haematol; 2012 Aug; 158(3):347-54. PubMed ID: 22594855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
